Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 63187-319

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 63187-319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-467-30.jpg (63187 467 30)

Label for Lisinopril HCTZ 20 mg / 25 mg tablets by Proficient Rx LP. The label indicates 90 tablets per bottle. Each tablet contains 20 mg of Lisinopril USP and 25 mg of Hydrochlorothiazide USP. Tablets are described as peach, round with specific debossed markings. Manufacturer is Lupin Limited, Nagpur, India.*

FDA Label Image

Lisinopril Usp (Lisiniprilhctz Figure 01)

Chemical structure diagram of lisinopril and hydrochlorothiazide. The image shows the molecular structure with labeled atoms and bonds, including a dihydrate component represented as ·2H2O.*

FDA Label Image

Hctz Usp (Lisiniprilhctz Figure 02)

Chemical structure diagram of the active ingredient in LISINOPRIL AND HYDROCHLOROTHIAZIDE tablet, showing molecular bonds and specific chemical groups of the compound.*

FDA Label Image

63187-319-30 (Lisiniprilhctz Figure 03)

Label for Lisinopril HCTZ 10 mg / 12.5 mg tablets by Proficient Rx LP. The label details a 30-tablet package with each tablet containing 10 mg Lisinopril and 12.5 mg Hydrochlorothiazide, described as blue, hexagonal tablets with debossed markings. It includes manufacturer information (Lupin Limited, India) and storage instructions, along with various barcodes and serial numbers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.